Results 11 to 20 of about 3,693 (191)

Case report: Spinal cord stimulation in the treatment of pediatric erythromelalgia

Frontiers in Neurology, 2023
IntroductionIn children, erythromelalgia is a rare chronic pain syndrome characterized by erythema, severe burning pain, and itching of affected feet. Unfortunately, there is no definitive therapy available currently.Case reportHere, we report a case of ...
Lei Zuo, Ai Su, Ying Shi, Nan Li, Shiyu Chen, XiaoQiu Yang   +5 more
doaj   +1 more source

Drug-Induced Acrocyanosis: Highlighting Venlafaxine as a Potential Culprit. [PDF]

Clin Case Rep
Resolution of venlafaxine‐induced acral cyanosis following discontinuation of the drug. ABSTRACT Acrocyanosis is a peripheral vascular disorder characterized by bluish discoloration of the distal extremities. While drug‐induced acrocyanosis has been associated with selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and other ...
Manandhar S, Rana A, Baniya R, Shrestha R.   +3 more
europepmc   +2 more sources

Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

SAGE Open Medical Case Reports, 2022
Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition.
Celine H Phong, Suzanne W Birmingham, Nathan W Rojek   +2 more
doaj   +1 more source

Endoscopic lumbar sympathectomy as a treatment option for primary erythromelalgia - case report and review

Jornal Vascular Brasileiro, 2023
Erythromelalgia is a rare disease, involving pain, edema, redness, and hyperthermia in the limbs. It is extremely refractory to drugs, has no defined treatment, and causes psychological comorbidities in the patient.
Marcelo de Paula Loureiro, Pietro Maran Novais, João Augusto Nocera Paulin, Daniel Benzecry de Almeida, Arlindo Nascimento de Lemos Junior   +4 more
doaj   +1 more source

Facial Erythromelalgia. [PDF]

Intern Med
Kitamura W, Kuyama S.
europepmc   +3 more sources

COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains

Acta Dermato-Venereologica, 2022
is missing (Short communication)
Florence Poizeau, Louise Triquet, Alain Dupuy   +2 more
doaj   +1 more source

Erythromelalgia: a cutaneous manifestation of neuropathy? [PDF]

Anais Brasileiros de Dermatologia, 2018
: The low prevalence of erythromelalgia, classified as an orphan disease, poses diagnostic and therapeutic difficulties. The aim of this review is to be an update of the specialized bibliography.
María Bibiana Leroux
doaj   +1 more source

Neurosurgical management for chronic and end-of-life pain in children: A systematic review. [PDF]

Pain Pract
Abstract Introduction Chronic and end‐of‐life pain in children is underreported and undermanaged. Current guidelines for pediatric chronic pain include medical and interventional modalities; however, the inclusion of neurosurgical treatments is uncommon and inconsistent. This systematic review presents the literature, and we provide recommendations for
Abdelmageed S, Villalba N, Bae G, Mossner JM, Adelhoefer SJ, Aravagiri K, Shah RD, Raskin JS.   +7 more
europepmc   +2 more sources

Linkage between increased nociception and olfaction via a SCN9A haplotype [PDF]

, 2013
Background and Aims: Mutations reducing the function of Nav1.7 sodium channels entail diminished pain perception and olfactory acuity, suggesting a link between nociception and olfaction at ion channel level.
Doehring, Alexandra, Heimann, Dirk, Hummel, Thomas, Lötsch, Jörn, Oertel, Bruno Georg   +4 more
core   +6 more sources

Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery. [PDF]

FASEB J
Developing an in vitro pain model that mimics essential features of the in vivo pain circuit requires careful consideration of multiple components and choices. These include selecting the cellular population for the model, choosing from the origin of nociceptors and other cells that are cultured, deciding between 3D or 2D dimensions, designing the ...
Khosrowshahi D, Lagae L, Bolander J.
europepmc   +2 more sources